Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers

BACKGROUND: Oxymorphone’s metabolism does not involve the hepatic cytochrome P450 (CYP) system. The effect of this pharmacokinetic feature of oxymorphone on opioid prescribing is unknown. OBJECTIVE: To assess the relative frequency with which oxymorphone and oxycodone (a CYP3A-metabolized opioid ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyle, D. Tyler, Woodworth, Tiffany S., Moeny, David, Staffa, Judy, Meyer, Tamra, Woods, Corinne, Welch, Emily C., Haynes, Kevin, Toh, Sengwee, Maro, Judith C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391052/
https://www.ncbi.nlm.nih.gov/pubmed/32347183
http://dx.doi.org/10.18553/jmcp.2020.26.5.668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391052/
https://www.ncbi.nlm.nih.gov/pubmed/32347183
http://dx.doi.org/10.18553/jmcp.2020.26.5.668

Ejemplares similares